Skip to main content

Imunon, Inc.

IMNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000749647

In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 6 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $753.8K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Imunon, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
1 insider, $38.1K in total
Insiders trading
1
Net value
−$38.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Imunon, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Imunon, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Tardugno Michael HExecutive Chairman of Board95,699Sep 15, 202611
Lindborg StacyPresident and CEO105,580Sep 15, 202611
Faller Douglas VincentChief Medical Officer41,288Sep 15, 20268
Eylward SusanGeneral Counsel and Corp Sec2,896Sep 1, 20267
Pellizzari Christine ADirector15,076Aug 4, 20263
Dentzer James EDirector21,897Aug 4, 20263
Fritz Frederick J.Director21,031Aug 4, 20263
Braun Donald PDirector15,499Aug 4, 20263
Anwer KhursheedChief Scientific Officer–Jan 6, 20261
Bragg KimberlyCFO–Jan 6, 20261
Church Jeffrey WayneCFO–Mar 18, 20240
Hazard SebastienChief Medical Officer20,000Dec 11, 20230
Chow Pok Yu AugustineDirector–Mar 21, 20230
Le Goff CorinnePresident and CEO53,000Mar 21, 20230
Tumminello Timothy JController–Jun 15, 20220
Hooper Robert WDirector–Jun 15, 20220
Kardaras Constantine JohnChief Accounting Officer10,000Jun 15, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 1, 2026 (view filing)4:06 PM ETAug 311 dayEylward SusanGeneral Counsel and Corp SecSSale−2.52K$1.56−$3.95K−46.6%2.90K after
Aug 17, 2026 (view filing)4:17 PM ETAug 17Same dayEylward SusanGeneral Counsel and Corp SecSSale−2.45K$1.63−$3.99K−45.8%2.90K after
Aug 4, 2026 (view filing)4:13 PM ETAug 31 dayEylward SusanGeneral Counsel and Corp SecSSale−2.54K$1.57−$3.98K−46.7%2.90K after
Jul 21, 2026 (view filing)4:15 PM ETJul 201 dayEylward SusanGeneral Counsel and Corp SecSSale−2.15K$1.78−$3.83K−42.6%2.90K after
Jul 7, 2026 (view filing)4:58 PM ETJul 61 dayEylward SusanGeneral Counsel and Corp SecSSale−920$1.88−$1.73K−24.1%2.90K after
Jun 29, 2026 (view filing)Jun 29Same dayEylward SusanGeneral Counsel and Corp SecSSale−11.8K$1.75−$20.6K−80.3%2.90K after
Jan 28, 2025 (view filing)Aug 20, 2024161 daysLateBraun Donald PDirectorPPurchase+25.0K$1.18+$29.5K+4,187.6%25.6K after
Aug 16, 2024 (view filing)Aug 151 dayLindborg StacyPresident and CEOPPurchaseImunon Common Stock+25.0K$0.98+$24.5K+10.5%264.2K after
Aug 16, 2024 (view filing)Aug 151 dayTardugno Michael HExecutive Chairman of BoardPPurchaseImunon Common Stock+25.0K$1.03+$25.8K+7.6%353.3K after
Apr 12, 2022 (view filing)Apr 12Same dayTardugno Michael HChairman, President and CEOPPurchaseCelsion Corporation Common Stock+4.00K$3.53+$14.1K+32.0%16.5K after
Apr 11, 2022 (view filing)Apr 83 daysFritz Frederick J.DirectorPPurchaseCelsion Corporation Common Stock+5.00K$4.05+$20.3K+73.9%11.8K after
Mar 3, 2022 (view filing)Mar 21 dayFritz Frederick J.DirectorPPurchaseCelsion Corporation Common Stock+2.00K$4.69+$9.38K+42.0%6.77K after
Oct 8, 2021 (view filing)Oct 71 dayFritz Frederick J.DirectorPPurchaseCelsion Corporation Common Stock+20.0K$0.88+$17.6K+38.8%71.5K after